Financials

  • Market Capitalization 3.77 B
  • Employee 601
  • Founded 2015
  • CEO -
  • Website www.arcusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00DQD26W3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.93
Relación precio/flujo de caja
30.46

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1520
IDYA
IDEAYA Biosciences, Inc. - Common Stock
39.77 USD-0.82%-4.95%+12.12%+22.07%3.84 B USD
1532
TNGX
Tango Therapeutics, Inc. - Common Stock
22.57 USD-1.18%-8.73%-15.88%+241.45%3.81 B USD
1545
DNLI
Denali Therapeutics Inc. - Common Stock
23.36 USD-1.68%-6.78%+2.23%+44.47%3.73 B USD
1546
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
33.50 USD-0.74%-9.68%+65.11%+264.13%3.73 B USD

Noticias